Thursday, May 2, 2019

USFDA for voluntary action by Sun Pharma on Dadra plant observations

The health regulator had inspected the company's Dadra facility from March 22 - March 29, 2019; and at the conclusion of the inspection, had issued a Form 483, with 11 observations to the company.

from Moneycontrol http://bit.ly/2UVp8bN

No comments:

Post a Comment

Trading Books